Medical research Books

Book SynopsisPeople with dementia are uniquely qualified to discuss the challenges of their condition and the features of effective support, but their voices are all too often drowned out in research and debates about policy. It''s time for that to change.Dementia Enquirers is an ambitious and novel programme of work which has tested out what it means for people with dementia to lead research and has developed a new ''driving seat'' approach to co-research.This ground-breaking book features 26 research projects led by groups of people with dementia, supported by group facilitators and academics, to make their voices heard. Topics include giving up driving, GP dementia reviews, living alone with dementia, and using AI platforms such as smart speakers. The book also describes how people with dementia shaped the entire programme, and addressed head-on issues such as ethics approval processes and complex research language.A key read for anyone involved in dementia support, this research

Read more less

Book SynopsisThe lymphatic system has been one of the most misunderstood systems in our bodies. Until now.Cardiothoracic surgeon Dr. Gerald M. Lemole explains why a healthy lymphatic flow aids our bodies in reducing toxins that contribute to disease and injury. In ten short chapters, Dr. Lemole demystifies the lymphatic system, describes how powerful it is and shows how to maintain a healthy lymph system to combat specific diseases and health problems - from heart disease to cognitive function to weight management.Featuring sidebars with charts and graphs that illustrate basic principles, Lymph & Longevity also includes menus, recipes and information on supplements, as well as basic yoga and meditation guides.Illuminating, informative, and practical this essential guide is timelier now than ever as we continue to work to protect ourselves and our communities against COVID-19 and other viruses.

Read more less

Book SynopsisFor students and researchers new to mixed methods,A Concise Introduction to Mixed Methods Research2e by renowned author John W. Creswell provides a brief and practical introduction to mixed methods. Many graduate students and researchers in the social, behavioral and health sciences may not have the time or resources to read long treatises or stacks of journal articles on mixed methods research. This text quickly describes the basics of setting up and conducting a study using this methodology. Chapters are short and follow the process of research, from ensuring skills for conducting research, acknowledging the steps in planning a study, designing studies with increasing complexity, planning sampling strategies and integration, and writing up the results of your study. Get started in mixed methods quickly with this brief primer.

Read more less

Book SynopsisNursing and Healthcare Research at a Glance is perfect for nursing and healthcare students, as well as newly qualified practitioners and anyone looking for a refresher or introduction to research.Trade Review"This book is an easy read and could appeal to all levels of nursing researchers, academics, students and anyone trying to rise up the clinical research ladder...The book takes the reader through all the necessary processes of forming a research question...All the essentials, such as how to conduct a literature review, systematic review and hierarchy of evidence are covered, as well as how to design a research questionnaire. A number of leaders in their field with vast experience in clinical research have contributed to this book, which makes it a valuable contribution to anyone wanting to expand their research knowledge." (Nursing Standard 22/03/2017)Table of ContentsContributors ix Preface xiii Part 1 What is healthcare research? 1 1 The research journey 2 2 Types of review and their purpose 4 3 Using databases to search the literature 6 4 Undertaking a Cochrane systematic review 8 5 Undertaking a Joanna Briggs Institute systematic review 10 6 Using EndNote 12 7 Using the PICO framework 14 8 Using the SPICE framework 16 9 Using grey literature in the quest for evidence 17 10 Why does research need evaluating? 18 11 Key issues in evaluating research 20 12 Critically reviewing a research paper 22 13 The hierarchy of evidence 24 14 Factors influencing research design 26 15 Patient and public involvement in research 28 16 Descriptive studies 30 17 Action research 32 18 Participatory health research 34 19 The ethics of healthcare research 36 20 Preparing a research proposal 38 21 Developing a patient research information pack 40 22 Getting the most from supervision 42 23 Writing a research report 44 24 Implementation of healthcare research 46 25 Barriers to research utilisation 48 26 Designing service evaluations 50 27 Designing audit tools for measuring compliance 52 Part 2 Quantitative research 55 28 Quantitative and qualitative research approaches 56 29 Understanding the randomised controlled trial 58 30 Quasi-experimental study design 60 31 Case-control studies 62 32 Cross-sectional design 64 33 Survey research methods 66 34 Factorial survey using vignettes 68 35 Triangulation in research 70 Part 3 Qualitative research 73 36 Ethnography 74 37 Qualitative observational methods 76 38 Phenomenology 78 39 Grounded theory 80 40 Classical grounded theory 82 41 Case study research 84 42 Focus group research 86 43 The Delphi process 88 44 The nominal group technique 90 45 The icon metaphor technique 92 46 Interpretative phenomenological analysis 94 47 Theory building 96 48 Qualitative interviewing 98 49 Thematic analysis 100 50 Social network analysis 102 51 Critical discourse analysis 104 52 Bricolage research methods 106 53 Narrative inquiry 108 54 Appreciative inquiry 110 55 Qualitative data analysis software packages 112 Part 4 Research techniques 115 56 Questionnaire design 116 57 Using web-based tools to design a questionnaire 118 58 Quality of life scales 120 59 The State-Trait Anxiety Inventory 122 60 Kelly’s repertory grids 124 61 Critical incident technique 126 Part 5 Conducting research with special groups 129 62 Conducting research with vulnerable groups 130 63 Research methods applicable to vulnerable groups 132 64 Draw and write/tell technique 134 65 Engaging children and young people in research 136 66 Photographic elicitation as a means of collecting data 138 67 Focus groups with children and young people 140 68 Critical ethnography with children 142 69 Using pre-test post-test designs with children 144 70 Conducting research with older adults 146 71 Conducting surveys with people with learning disabilities 148 72 Conducting focus groups with people with learning disabilities 150 73 People with learning disabilities as co-researchers 152 74 Undertaking research with family carers 154 75 Obtaining consent from vulnerable groups 156 76 Living lab approach 158 Part 6 Historical research 161 77 What is historiography? 162 78 Source criticism 164 79 Critiquing historical research 166 80 Oral tradition 168 Part 7 Educational research 171 81 Secondary data analysis: analysing documents 172 82 Traditional annotation and coding 174 83 Video-View-Point 176 84 Ethnography and healthcare education 178 85 Semantic annotation of skills-based sessions 180 86 Actor network theory 182 Part 8 Appendices 185 1 Sampling 186 2 Calculating the required sample size 188 3 Estimating population means 188 4 Research data management 189 5 Types of data 190 6 Data requirement planning 190 7 Descriptive statistics 191 8 Frequency distribution 191 9 Hypothesis testing and statistical significance 192 10 Choosing the right test 192 11 Non-parametric tests 193 12 Student’s t-test 193 13 Analysis of variance 194 14 Tabulating data and the chi-squared test 195 15 Correlation 196 16 Measuring and interpreting correlation 197 17 Simple linear regression 199 18 Meta-analysis 200 19 Propensity score matching 201 20 Mokken scaling 203 Index 205

Read more less

Book SynopsisThe story of the search for p53--the most important gene in medicine.All of us have lurking in our DNA a most remarkable gene: it is known simply as p53 and its job is to protect us from cancer. p53: The Gene that Cracked the Cancer Code tells the story of the discovery of the gene and of medical science''s mission to unravel its mysteries and get to the heart of what happens in our cells when they turn cancerous. When all is well, this gene constantly scans our cells to ensure that when they grow and divide as part of the routine maintenance of our bodies, they do so without mishap. If a cell makes a mistake in copying its DNA during the process of division, p53 stops it in its tracks, sending in the repair team before allowing the cell to carry on dividing. Cancer cannot develop unless p53 itself is damaged or handicapped by some other fault in the system. Not surprisingly, p53 is the most studied single gene in history. Through the personal acTrade ReviewMore than any textbook, article, or lecture could, this book offers a sip of contagious enthusiasm and a conviction that scientists will eventually “crack the cancer code" * Science *Armstrong’s book is genuinely engrossing on many levels, and the story is very well told. It has considerable depth, yet sufficient clarity to be able to reach a wide audience ... a highly readable, well-written and crafted book. * Cell *A succinct, accessible study of humanity's genetic bulwark against cancer. * Nature *One of the best accounts I’ve read of how science is actually performed. -- Peter Forbes * The Guardian *Armstrong paints a very human picture ... Not only does Armstrong make p53 understandable but she also sheds light on the scientific method. In an age of government austerity, highlighting the importance of scientific research is also a gift. * The Lancet *Ms. Armstrong¹s book comes alive in the sections where she explores cancer¹s human toll, including the devastating experience of families with rare genetic mutations, such as Li-Fraumeni syndrome, which leaves children of parents with a faulty gene vulnerable to cancer at almost any age. She also captures the excitement of researchers as they come upon eureka moments. * Wall Street Journal *Table of ContentsPreface Chapter 1: Flesh of our Own Flesh Chapter 2: The Enemy Within Chapter 3: Discovery Chapter 4: Unseeable Biology Chapter 5: Cloning the Gene Chapter 6: A Case of Mistaken Identity Chapter 7: A New Angle on Cancer Chapter 8: p53 Reveals its True Colours Chapter 9: Master Switch Chapter 10: ‘Guardian of the Genome’ Chapter 11: Of Autumn Leaves and Cell Death Chapter 12: Of Mice and Men Chapter 13: The Guardian’s Gatekeeper Chapter 14: The Smoking Gun Chapter 15: Following the Fingerprints Chapter 16: Cancer in the Family Chapter 17: The Tropeiro Connection? Chapter 18: Jekyll and Hyde Chapter 19: Cancer and Ageing: A Balancing Act Chapter 20: The Treatment Revolution Dramatis Personae Glossary Notes on Sources Acknowledgements Index

Read more less

Book SynopsisA clinical psychiatrist explores the effects of DMT, one of the most powerful psychedelics known.Trade Review"Fascinating and provocative. A remarkable exploration of the boundaries of science and consciousness itself." * Rupert Sheldrake, author of The Presence of the Past *"Rick Strassman's pioneering research work with DMT, a natural psychedelic drug used by Amazonian Indians, raises fascinating questions about the neurochemical basis of experience and the feasibility of conducting human research with mind-altering drugs in a university medical center. Truly adventurous reading!" * Andrew Weil, M.D., author of Spontaneous Healing *"This book is essential reading for anyone with an interest in the mind, philosophy, the nature of reality, and spirituality." * Karl Jansen, M.D., Ph.D. *"DMT: The Spirit Molecule points the way beyond the present impasse of the reigning 'drug abuse' paradigm." * Jonathan Ott, author of The Age of Entheogens and Hallucinogenic Plants of North America *"The most extensive scientific study of the mental and perceptual effects of a psychedelic drug since the 1960s." * Ralph Metzner, Ph.D., author of Ayahuasca: Consciousness and the Spirits of Nature *"Strassman's important research contributes to a growing awareness that we inhabit a multi-dimensional universe." * John Mack, MD Professor of Psychiatry, Harvard Medical School, author of Abduction and Passport to t *"Strassman raises vital questions about the origin of spiritual experiences and the nature of consciousness." * Larry Dossey MD, author of Reinventing Medicine, and Healing Words; Executive Editor, Alternative Th *"DMT: The Spirit Molecule is a fascinating journey into the research of psychedelics. . . . The questions and possible explanations about the endogenous presence of DMT that he raises not only enlarge the discussion about psychedelics but also expand our understanding of the nature of consciousness." * Jule Klotter, Townsend Letter for Doctors & Patients - July, 2001 *"This book will be of profound interest to . . . anyone with a deep interest in the study of consciousness, visionary states and/or psycho-pharmacology." * J. P. Harpignies, Lapis *"Strassman's psychonauts regularly found themselves hurtled into alien laboratories, high-tech nurseries, and Day-Glo hieroglyphic hypercubes." * Erik Davis, The Village Voice *"DMT: the Spirit Molecule is an enriching journey into one scientist's courageous attempt to solve a bit more of the brain/mind/spirit mystery at the center of human existence." * Vicki Ecker, UFO Magazine, December-January 2002 *"What you will find is a thoughtful, well-written report about another of life's mysteries." * James Dekorne, Fortean Times, November 2001 *"Strassman's research was an important step, one that will potentially illuminate the path for future researchers and volunteers alike, and this book is a great contribution to the ongoing dialogue surrounding psychedelics." * Scotto, Trip, Fall 2001 *"This is probably the most thorough book on the psychedelic, DMT--its history, chemistry, uses (legal and illegal), and its effects. This is a very compelling, thoughtful book, written by a scrupulous scientist with the soul of a meditator." * The Book Reader, Spring/Summer 2002 *"The account of the project is an excellent inside view of human drug studies, especially those with psychedelics." * Paul Von Ward, The AHP Perspective, June/July 2002 *"This book is a highly readable, intriguing, provocative description of Rick Strassman's theories and research concerning the effects of DMT." * Alissa Hirshfeld-Flores, M.A., LMFT, The American Journal of Psychiatry, August 2002 *"Rick Strassman's experimentation with the psychoactive substance DMT is taking up where Leary's 1950/60's LSD experiments stopped." * Rev. Dr. S. D'Montford, New Dawn, Jan-Feb 2006 *"[Strassman's] account, written more for the layman than the specialist, is ground-breaking, and raises the interesting question as to what is truly a psychedelic experience." * Peter Fenwick, The Scientific and Medical Network, Summer 2007 *"Near-death experiences. Alien abductions. Lucid dreams. Even gods and goddesses. Try DMT for an explanation and it all holds together. It's brain chemistry. It's neuropharmacology. It's quite possibly other realms. Whatever it is, it's the new frontier, a closer examination of consciousness, and it's very, very exciting!" * betaphilings.com, Dec 2008 *"[Strassman] is a gifted writer and makes scientific jargon easy to read. The book gives very interesting examples of what the volunteers envisioned and how they felt throughout the experiences. . . . It is important for us as a society to look at legal, controlled, and supervised experimentation with psychoactive drugs with open minds, and with eventual scientific benefit in mind." * Levi Cox, FLC Law and Society Science & Metaphysics Blog, Feb 2009 *"Fascinating stuff! If this kind of thing interests you then pick up this book today." * Loretta Nall, blog by former Alabama Gubernatorial Candidate, June 2009 *"In the end, I felt the most important element of the book was the contextualization of the questions most important in psychedelic research. Strassman keenly recognizes and extrapolates the areas that appear to be most vital in the further study and theory of psychedelics." * The Psychedelic Press UK, Sept 2009 *“Highly readable, intriguing, provocative. . . . [An] intellectually courageous book. . . . Will be of great use both to researchers and clinicians, as well as to laypeople.” * American Journal of Psychiatry, 2002 *“A dazzling journey through psychedelic drug experimentation and a tantalizing peek into a new model of how the brain and mind work. Strassman’s research points toward a physiological basis for spirit and its interaction with the human body; his data suggests that our brain chemistry allows us access to other realms of existence just when we need it most, and his story recounts both the dangers and promises of entering this brave new world.” * Bruce Greyson, Editor, Journal of Near-Death Studies *Table of ContentsDMT: The Spirit Molecule A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences Acknowledgments Introduction Prologue: First Sessions Part I: The Building Blocks Part II: Conception and Birth Part III: Set, Setting, and DMT Part IV: The Sessions Part V: Taking Pause Part VI: What Could and Might Be

Read more less

Book Synopsis Inspire your students to be theoretical thinkers, innovative advocates, and agents for change.Focused on cultivating the next generation of scholars, this highly respected classic demystifies theory, charts strategies to use in developing and advancing theory, and provides tools and best practices in evaluating progress in the discipline. Based on the feedback of nursing students, this edition was updated to be more accessible without losing the necessary rigor to foster critical thinking. Meleis provides a developmental and historical review of theoretical nursing and helps readers develop analytic skills and integrate knowledge into a coherent whole. By embarking on the journey of nursing theory, practicing nurses will find ways to improve everyday practice, as well as develop theories that capture their expertise.Highlights of the Sixth EditionKey Topics Paradigms that influenced nursing thought, such as feminism

Read more less

Book Synopsis

Read more less

Book Synopsis Ben Goldacre’s wise and witty bestseller, shortlisted for the Samuel Johnson Prize, lifts the lid on quack doctors, flaky statistics, scaremongering journalists and evil pharmaceutical corporations. Trade Review‘From an expert with a mail-order PhD to debunking the myths of homeopathy, Ben Goldacre talking the reader through some notable cases and shows how to you don’t need a science degree to spot “bad science” yourself.’ Independent (Book of the Year) ‘His book aims to teach us better, in the hope that one day we write less nonsense.’ Daily Telegraph (Book of the Year) ‘For sheer savagery, the illusion-destroying, joyous attack on the self-regarding, know-nothing orthodoxies of the modern middle classes, “Bad Science” can not be beaten. You’ll laugh your head off, then throw all those expensive health foods in the bin.’ Trevor Philips, Observer (Book of the Year) ‘Unmissable…laying about himself in a froth of entirely justified indignation, Goldacre slams the mountebanks and bullshitters who misuse science. Few escape: drug companies, self-styled nutritionists, deluded researchers and journalists all get thoroughly duffed up. It is enormously enjoyable.’ The Times (Book of the Year)

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThe remarkable stories of the world''s most famous body parts.Louis XIV''s rear end inspired the British National Anthem. Queen Victoria''s armpit led to the development of antiseptics.Robert Jenkin''s ear started a war.All too often, historical figures feel distant and abstract; more myth and legend than real flesh and blood. These stories of bodies and its parts remind us that history''s most-loved, and most-hated, were real breathing creatures who inhabited organs and limbs just like us - until they''re cut off that is.Medical historian Dr Suzie Edge investigates over 40 cases of how we''ve used, abused, dug up, displayed, experimented on, and worshipped body parts, including why Percy Shelley''s heart refused to burn; how Yao Niang''s toes started a 1000 year long ritual; why a giant''s bones are making us rethink medical ethics; and the strange case of Hitler''s right testicle.

Read more less

Book SynopsisHistory is an erudite teacher, from which we can learn invaluable lessons, both positive and negative. This is especially true for drug discovery and development. While creativity demands we think outside of the box, past successes and failures in creating medicines are gifts that keep on giving. Creation of human medicines involves so many scientific and medical disciplines that history is our indispensable resources of institutional knowledge. This volume in a new series sheds light on successes to emulate and pitfalls to avoid in oncology drug discovery. The series editor blends education with engaging content for aspiring drug developers and helps to foster a deeper understanding.

Read more less

Book SynopsisDrawing on the latest international research, leading physician and healthcare expert Professor Geoffrey Guy examines how quantum phenomena affect processes as diverse as the functioning of the brain and the body's approach to combating inflammation and disease. He shows how we may need to rethink the ways in which energy and information are carried round our nervous system.This groundbreaking book assesses the implications for cancer treatment and mental disorders and reopens discussion of areas such as light therapy. It also raises questions about the potentially damaging effects of space travel on astronauts' health and how they might have to be mitigated.Key to the author's approach is his ability to explain lucidly our current knowledge while drawing in cutting-edge research. Written for the general reader, but with a scope and depth that will satisfy medical professionals, Quantum Biology reveals the latest findings from this most fascinating medical frontier.

Read more less

Book SynopsisAt a time when medicine is a highly sought-after career for Indian women, it is hard to imagine what it was like for the pioneers. The story of how firmly they were bound in fetters of family, caste and society, and how fiercely they fought to escape, needs to be told. In Lady Doctors, Kavitha Rao unearths the extraordinary stories of six women from the 1860s to the 1930s, who defied the idea that they were unfit for medicine by virtue of their gender. From Anandibai Joshi, who broke caste rules by crossing an ocean, to Rukhmabai Raut, who escaped a child marriage, divorced her husband and studied to be a doctor; from Kadambini Ganguly, who took care of eightchildren while she worked, to child widow Haimabati Sen, who overcame poverty and hardship-these women had a profound and lasting impact. And in their forgotten lives lie many lessons for modern women. In truth, the compelling stories of these radical women have been erased from our textbooks and memories, because histories have mostly been written by men, about men. In an immensely readable narrative, and with impeccable research, Lady Doctors rectifies this omission.

Read more less

Book SynopsisThis clear and concise handbook considers the stages of the research process in logical order, from planning of the project through to dissemination of the findings.Trade Review"This textbook...is a useful and concise resource for "first time researchers" in any practice setting...One of the strengths of this text is that it specifically devotes a section to "Writing up and Dissemination of the Findings", as an integral component of the research process...For those working in hospital pharmacy this section is especially useful as it emphasises the need to communicate research findings in order to effect change in the local setting, and how this might be done...Overall, this text is best read in its entirety (a fairly easy read!) as an introduction to research, and would be useful to anyone commencing a research project, not just research students and their supervisors. The text should be part of any hospital pharmacy's library of resources, and a prerequisite text for those taking on roles involving research activities at any level"Dr Beata V. Bajorek, Academic Pharmacist, University of Sydney, Journal of Pharmacy Practice and Research 41(1) 2011. -- Beata V. Bajorek * Journal of Pharmacy Practice and Research *Table of ContentsPart 1 Preparation, planning and management 1. Introduction 2. Types of pharmacy practice projects 3. Setting up the project, protocol development and ethics 4. Time management and working with others 5. Patient and public involvement 6. For supervisors Part 2 Scientific enquiry and research/service evaluation methodology 7. A scientific approach to your research 8. Reviewing the literature 9. Study design 10. Sources of information, datasets, sampling and recruitment 11. Data collection: survey research and questionnaires 12. Data collection: interviews and focus groups 13. Data collection: prospective methods 14. Existing datasets and secondary analyses 15. Data processing and analysis Part 3 Writing up and dissemination of finding 16. Writing the project report/research paper 17. Dissemination of the findings

Read more less

Book SynopsisThis handbook is a definitive, up-to-date, and succinct text covering the legislative requirements, scientific foundations, and clinical good practice necessary for clinical, academic, and healthcare research.Trade ReviewThe Oxford Handbook of Clinical and Healthcare Research packs a lot of information into a literally hand-sized ... book, with precise writing." * Norman M. Goldfarb, Journal of clinical research best practises *A unique handbook that covers all the stages of clinical research along with a clear description of the regulations / processes that current researchers need to comply with. This truly addresses a much needed gap in the various research handbooks. * Dr Puja Myles, Associate Professor Health Protection and Epidemiology; Nottingham University *Table of Contents1. Research - How and Why ; 2. Navigating Research Methods: Basic concepts in biostatistics and epidemiology ; 3. Navigating Research Methods: Quantitative and clinical / epidemiological methods ; 4. Navigating Research Methods: Qualitative methods ; 5. Navigating Research Methods: Evidence Based Medicine (EBM) ; 6. Navigating Research Methods: Critical ap-praisal ; 7. Navigating Research Methods: Clinical Audit ; 8. Setting the scene and ICH-GCP in clinical and healthcare research ; 9. Informed consent in a research setting ; 10. Ethics of clinical and healthcare research: general considerations, Mental Capacity Act, Human Tissue Act ; 11. Role and Responsibilities: Investigators and Research Team ; 12. Role and Responsibilities: Sponsor ; 13. Monitoring ; 14. Clinical Trial Design ; 15. Clinical Trial Protocols: Study Protocol ; 16. Data Capture Tools: Case Report Form (CRF) ; 17. Clinical Trial Supplies: IMPs ; 18. IMP Accountability ; 19. Safety Reporting ; 20. Data management ; 21. Research Project Management ; 22. Essential Documents ; 23. Archiving ; 24. Audits and Inspections ; 25. Fraud and Misconduct ; 26. Authorship ; 27. Publication process ; 28. Start-up toolkit: from funding an idea, through implementation, to achieving an impact

Read more less

Book SynopsisTrade Review"Neurostimulation for Epilepsy is a comprehensive and authoritative book previously unavailable in this emerging treatment field that provides a detailed exploration of the principles, device technology, and applications of neurostimulation for epilepsy. With contributions from a team of expert researchers and clinicians, the book covers various neurostimulation techniques, including vagus nerve stimulation, deep brain stimulation, responsive neurostimulation, and non-invasive brain stimulation. The book provides insights into the latest advancements in next-generation brain sensing and stimulation devices, as well as their impact on neurocognitive outcomes and quality of life. This work is an invaluable resource for researchers, clinicians, and anyone seeking a deeper understanding of the role of neurostimulation in managing epilepsy." -- Kate Davis, MD, MS, FAES, FANA, Associate Professor of Neurology, Director, Penn Epilepsy Center "Dr. Rao has assembled an impressive group of world-renowned experts in this effort. The book covers all aspects of neurostimulation for epilepsy, from basic principles to clinical trial results to practical advice to possible future applications. In addition to thorough discussions of the "big three" (VNS, DBS and RNS), the book also covers epicranial stimulation and emerging methods of noninvasive stimulation including transcranial magnetic stimulation and low intensity focused ultrasound. There are chapters on applications of the long-term data obtained from these systems, and the effects of neurostimulation on quality of life, cognition and mood. The chapters are well written, thorough yet concise, and very well referenced. There is something for everyone in this book, from those just starting to learn about neurostimulation to experts using it regularly. This is a welcome addition to the library for anyone involved in treating refractory epilepsy or performing related research." -- Lawrence J. Hirsch, MD, Professor of Neurology, Chief, Division of Epilepsy and EEG, Co-Director, Comprehensive Epilepsy Center, Yale University School of Medicine"I highly recommend "Neurostimulation for Epilepsy." It is a comprehensive guide and offers valuable insights. The book covers the essential topics in the various neuromodulation therapies used in epilepsy. This manual provides a balance blend of clinical expertise and educational content, making it an excellent resource for experienced practitioners, researchers as well as those in the early stages of their career." -- Dileep Nair, MD, Professor of Neurology, CCLCM/CWRU; Head of Section of Adult Epilepsy, Neurological Institute; Cleveland ClinicTable of Contents1. Principles of neurostimulation Andreas Schulze-Bonhage 2. Neurostimulation device technology Eric Y. Chow and Peng Cong 3. Vagus nerve stimulation James W. Wheless, Andrew J. Gienapp, and Basanagoud Mudigoudar 4. Responsive neurostimulation David E. Burdette and Barbara E. Swartz 5. Deep brain stimulation (DBS) of thalamus for epilepsy Robert Fisher 6. Epicranial focal cortex stimulation with the EASEE system Andreas Schulze-Bonhage 7. Noninvasive brain stimulation for epilepsy Keith Starnes, Andreas Schulze-Bonhage, and Brian Lundstrom 8. Applications of long-term data from neurostimulation devices Patricia Dugan and Vikram R. Rao 9. Next-generation brain sensing, stimulation, and adaptive control devices for epilepsy Gregory A. Worrell and Vaclav Kremen 10. Quality of life, neurocognitive outcomes, and mood effects with neurostimulation devices Kristen Arredondo and Anup D. Patel

Read more less

Book Synopsis

Read more less

Book SynopsisThis handbook provides an in-depth review of information across the developmental spectrum of gene and cell therapy products. From introductory information to state-of-the-art technologies and concepts, the book provides insights into upstream processes such as vector design and construction, purification, formulation and fill/finish, as well as delivery options. Planning steps for compliance with current good manufacturing practice (cGMP) to readiness for chemistry, manufacturing and controls (CMC) are also discussed. This book wraps up with examples of successes and pitfalls addressed by experts who have navigated the multiple challenges that are part of any innovative endeavor.Features Provides the most up-to-date information on the development of gene therapy, from the technology involved to gene correction and genome editing Discusses siRNA, mRNA, and plasmid manufacturing Describes the importance of supplier-sponsor synergies on the path to commercialization Written for a diverse audience with a large number of individuals in the core technologies and supportive practices It is intended as a one-stop resource for the availability of state-of-the-art information related to cell and gene therapy products for researchers, scientists, management and other academic and research institutions.

Read more less

Book SynopsisThis thoroughly revised and updated second edition provides a step-by-step approach to application of participatory approaches to qualitative data collection (including structured and unstructured interviews, observations, and group interviews) and data analysis (including constant comparative method, coding schemes, and theme memo).Table of ContentsFigures and Tables xi Foreword xiii David Satcher Dedication xvii Acknowledgments ixx The Editors xxiii The Contributors xxvii PART ONE: INTRODUCTION TO METHODS FOR COMMUNITY-BASED PARTICIPATORY RESEARCH FOR HEALTH 1 1. Introduction to Methods for CBPR for Health 3 Barbara A. Israel, Eugenia Eng, Amy J. Schulz, Edith A. Parker PART TWO: PARTNERSHIP FORMATION AND MAINTENANCE 39 2. Developing and Maintaining Partnerships with Communities 43 Bonnie Duran, Nina Wallerstein, Magdalena M. Avila, Lorenda Belone, Meredith Minkler, Kevin Foley 3. Strategies and Techniques for Effective Group Process in CBPR Partnerships 69 Adam B. Becker, Barbara A. Israel, Jeanette Gustat, Angela G. Reyes, Alex J. Allen III 4. Infrastructure for Equitable Decision Making in Research 97 Michael Yonas, Robert Aronson, Nettie Coad, Eugenia Eng, Regina Petteway, Jennifer Schaal, Lucille Webb PART THREE: COMMUNITY ASSESSMENT AND DIAGNOSIS 127 5. Insiders and Outsiders Assess Who Is “The Community”: Participant Observation, Key Informant Interview, Focus Group Interview, and Community Forum 133 Eugenia Eng, Karen Strazza, Scott D. Rhodes, Derek Griffith, Kate Shirah, Elvira Mebane 6. Using Ethnography in Participatory Community Assessment 161 Jean J. Schensul, Marlene J. Berg, Saritha Nair PART FOUR: DEFINE THE ISSUE, DESIGN AND CONDUCT THE RESEARCH 189 7. Community-Based Participation in Survey Design and Implementation: The Healthy Environments Partnership Survey 197 Amy J. Schulz, Shannon N. Zenk, Srimathi Kannan, Barbara A. Israel, Carmen Stokes 8. Using a CBPR Approach to Develop an Interviewer Training Manual with Members of the Apsáalooke Nation 225 Suzanne Christopher, Linda Burhansstipanov, Alma Knows His Gun McCormick, Vanessa Watts Simonds 9. The Application of Focus Group Methodologies to CBPR 249 Edith C. Kieffer, Yamir Salabarría-Pen˜a, Angela M. Odoms-Young, Sharla K. Willis, Gloria Palmisano, J. Ricardo Guzmán 10. Development, Evolution, and Implementation of a Food Environment Audit for Diverse Neighborhoods 277 Shannon N. Zenk, Amy J. Schulz, Betty T. Izumi, Sharon Sand, Murlisa Lockett, Angela Odoms-Young 11. CBPR and Ethnography: The Perfect Union 305 Nicole S. Berry, Chris McQuiston, Emilio A. Parrado, Julio César Olmos-Mun˜iz 12. What’s with the Wheezing?: Methods Used by the Seattle-King County Healthy Homes Project to Assess Exposure to Indoor Asthma Triggers 335 James Krieger, Carol A. Allen, Tim K. Takaro PART FIVE: DOCUMENTATION AND EVALUATION OF PARTNERSHIPS 365 13. Documentation and Evaluation of CBPR Partnerships: The Use of In-Depth Interviews and Closed-Ended Questionnaires 369 Barbara A. Israel, Paula M. Lantz, Robert J. McGranaghan, J. Ricardo Guzmán, Richard Lichtenstein, Zachary Rowe PART SIX: FEEDBACK, INTERPRETATION, DISSEMINATION, AND APPLICATION OF RESULTS 399 14. Developing and Implementing Guidelines for Dissemination: The Experience of the Community Action Against Asthma Partnership 405 Edith A. Parker, Thomas G. Robins, Barbara A. Israel, Wilma Brakefi eld-Caldwell, Katherine K. Edgren, Ashley O’Toole, Donele Wilkins, Stuart Batterman, Toby Lewis 15. Collaborative Data Collection, Interpretation, and Action Planning in a Rural African American Community: Men on the Move 435 Elizabeth A. Baker, Freda Motton, Ellen Barnidge, Frank Rose III 16. Collaborative Mapping for Health Equity: Making Place Visible 463 Jason Corburn, Anna Yun Lee, Nehanda Imara, Samara Swanston 17. Photovoice as a CBPR Method: A Case Study with African American Breast Cancer Survivors in Rural Eastern North Carolina 489 Ellen D. S. López, Naomi Robinson, Eugenia Eng 18. Methods for Community-Based Participatory Policy Work to Improve Food Environments in New York City 517 Emma Tsui, Milyoung Cho, Nicholas Freudenberg 19. Citizens, Science, and Data Judo: Leveraging Secondary Data Analysis to Build a Community-Academic Collaborative for Environmental Justice in Southern California 547 Rachel Morello-Frosch, Manuel Pastor, James Sadd, Michele Prichard, Martha Matsuoka APPENDIXES 579 A. Instructions for Conducting a Force Field Analysis 581 Adam B. Becker, Barbara A. Israel, Alex J. Allen III B. Full Value Contract 585 Michael Yonas, Robert Aronson, Nettie Coad, Eugenia Eng, Regina Petteway, Jennifer Schaal, Lucille Webb C. Collaborative Revised Bylaws: Adopted/Amended: (Month, Day, Year) 589 Michael Yonas, Robert Aronson, Nettie Coad, Eugenia Eng, Regina Petteway, Jennifer Schaal, Lucille Webb D. Community Member Key Informant Interview Guide 601 Eugenia Eng, Karen Strazza, Scott D. Rhodes, Derek M. Griffith, Kate Shirah, Elvira Mebane E. Selected Healthy Environments Partnership Measures by Survey Categories, Indicating Source of Identification for Inclusion and Scale Items 605 Amy J. Schulz, Shannon Zenk, Srimathi Kannan, Barbara A. Israel, Carmen Stokes F. Promoting Healthy Lifestyles Among Women: Focus Group Summary Analysis Form: Eastside and Southwest Detroit—Procedures and Example Questions 613 Edith C. Kieffer, Yamir Salabarría-Pen˜a, Angela M. Odoms-Young, Sharla K. Willis, Gloria Palmisano, J. Ricardo Guzmán G. Field Notes Guide 619 Nicole S. Berry, Chris McQuiston, Emilio A. Parrado, Julio César Olmos-Muñiz H. In-Depth, Semi-structured Interview Protocol: Detroit Community-Academic Urban Research Center, Detroit URC Board Evaluation 1996–2002 623 Barbara A. Israel, Paula M. Lantz, Robert J. McGranaghan, J. Ricardo Guzmán I. Closed-Ended Survey Questionnaire: Detroit Community-Academic Urban Research Center, Detroit URC Board Evaluation 1997–2007 627 Barbara A. Israel, Paula M. Lantz, Robert J. McGranaghan, J. Ricardo Guzmán, Richard Lichtenstein, Zachary Rowe J. Philosophy and Guiding Principles for Dissemination of Findings of Community Action Against Asthma Including Authorship of Publications and Presentations, Policies and Procedures, Access to Data, and Related Matters 639 Edith A. Parker, Thomas G. Robins, Barbara A. Israel, Wilma Brakefi eld-Caldwell, Katherine K. Edgren, Donele J. Wilkins K. Inspirational Images Project: Fact Sheet and Informed Consent Form for Study Participants 645 Ellen D. S. López, Naomi Robinson, Eugenia Eng L. Inspirational Images Project: Informed Consent Form for Adults Who May Appear in Photographs 651 Ellen D. S. López, Naomi Robinson M. Southern California Environmental Justice Collaborative: Partnership Agreed-Upon Mechanism for Deciding on Research Activities 655 Communities for a Better Environment, Liberty Hill Foundation, and the Research Team Index 659

Read more less

Book SynopsisA practical guide to network meta-analysis with examples and code In the evaluation of healthcare, rigorous methods of quantitative assessment are necessary to establish which interventions are effective and cost-effective.Table of ContentsPreface xiii List of Abbreviations xxi About the Companion Website xxv 1 Introduction to Evidence Synthesis 1 1.1 Introduction 1 1.2 Why Indirect Comparisons and Network Meta-Analysis? 2 1.3 Some Simple Methods 4 1.4 An Example of a Network Meta-Analysis 6 1.5 Assumptions Made by Indirect Comparisons and Network Meta-Analysis 9 1.6 Which Trials to Include in a Network 12 1.6.1 The Need for a Unique Set of Trials 12 1.7 The Definition of Treatments and Outcomes: Network Connectivity 14 1.7.1 Lumping and Splitting 14 1.7.2 Relationships Between Multiple Outcomes 15 1.7.3 How Large Should a Network Be? 15 1.8 Summary 16 1.9 Exercises 16 2 The Core Model 19 2.1 Bayesian Meta-Analysis 19 2.2 Development of the Core Models 20 2.2.1 Worked Example: Meta-Analysis of Binomial Data 21 2.2.1.1 Model Specification: Two Treatments 21 2.2.1.2 WinBUGS Implementation: Two Treatments 25 2.2.2 Extension to Indirect Comparisons and Network Meta-Analysis 32 2.2.2.1 Incorporating Multi-Arm Trials 35 2.2.3 Worked Example: Network Meta-Analysis 36 2.2.3.1 WinBUGS Implementation 37 2.3 Technical Issues in Network Meta-Analysis 50 2.3.1 Choice of Reference Treatment 50 2.3.2 Choice of Prior Distributions 51 2.3.3 Choice of Scale 53 2.3.4 Connected Networks 54 2.4 Advantages of a Bayesian Approach 55 2.5 Summary of Key Points and Further Reading 56 2.6 Exercises 57 3 Model Fit, Model Comparison and Outlier Detection 59 3.1 Introduction 59 3.2 Assessing Model Fit 60 3.2.1 Deviance 60 3.2.2 Residual Deviance 61 3.2.3 Zero Counts* 62 3.2.4 Worked Example: Full Thrombolytic Treatments Network 62 3.2.4.1 Posterior Mean Deviance, D̅model 62 3.2.4.2 Posterior Mean Residual Deviance, D̅res 64 3.3 Model Comparison 66 3.3.1 Effective Number of Parameters, pD 68 3.3.2 Deviance Information Criterion (DIC) 69 3.3.2.1 *Leverage Plots 70 3.3.3 Worked Example: Full Thrombolytic Treatments Network 70 3.4 Outlier Detection in Network Meta-Analysis 75 3.4.1 Outlier Detection in Pairwise Meta-Analysis 75 3.4.2 Predictive Cross-Validation for Network Meta-Analysis 79 3.4.3 Note on Multi-Arm Trials 85 3.4.4 WinBUGS Code: Predictive Cross-Validation for Network Meta-Analysis 86 3.5 Summary and Further Reading 89 3.6 Exercises 90 4 Generalised Linear Models 93 4.1 A Unified Framework for Evidence Synthesis 93 4.2 The Generic Network Meta-Analysis Models 94 4.3 Univariate Arm-Based Likelihoods 99 4.3.1 Rate Data: Poisson Likelihood and Log Link 99 4.3.1.1 WinBUGS Implementation 100 4.3.1.2 Example: Dietary Fat 101 4.3.1.3 Results: Dietary Fat 104 4.3.2 Rate Data: Binomial Likelihood and Cloglog Link 105 4.3.2.1 WinBUGS Implementation 107 4.3.2.2 Example: Diabetes 109 4.3.2.3 Results: Diabetes 112 4.3.3 Continuous Data: Normal Likelihood and Identity Link 114 4.3.3.1 Before/After Studies: Change from Baseline Measures 115 4.3.3.2 Standardised Mean Differences 115 4.3.3.3 WinBUGS Implementation 116 4.3.3.4 Example: Parkinson’s 117 4.3.3.5 Results: Parkinson’s 119 4.4 Contrast-Based Likelihoods 120 4.4.1 Continuous Data: Treatment Differences 121 4.4.1.1 Multi-Arm Trials with Treatment Differences (Trial-Based Summaries) 122 4.4.1.2 *WinBUGS Implementation 123 4.4.1.3 Example: Parkinson’s (Treatment Differences as Data) 125 4.4.1.4 Results: Parkinson’s (Treatment Differences as Data) 127 4.5 *Multinomial Likelihoods 127 4.5.1 Ordered Categorical Data: Multinomial Likelihood and Probit Link 128 4.5.1.1 WinBUGS Implementation 132 4.5.1.2 Example: Psoriasis 133 4.5.1.3 Results: Psoriasis 137 4.5.2 Competing Risks: Multinomial Likelihood and Log Link 138 4.5.2.1 WinBUGS Implementation 140 4.5.2.2 Example: Schizophrenia 141 4.5.2.3 Results: Schizophrenia 143 4.6 *Shared Parameter Models 146 4.6.1 Example: Parkinson’s (Mixed Treatment Difference and Arm-Level Data) 147 4.6.2 Results: Parkinson’s (Mixed Treatment Difference and Arm-Level Data) 148 4.7 Choice of Prior Distributions 149 4.8 Zero Cells 149 4.9 Summary of Key Points and Further Reading 150 4.10 Exercises 151 5 Network Meta-Analysis Within Cost-Effectiveness Analysis 155 5.1 Introduction 155 5.2 Sources of Evidence for Relative Treatment Effects and the Baseline Model 156 5.3 The Baseline Model 158 5.3.1 Estimating the Baseline Model in WinBUGS 158 5.3.2 Alternative Computation Methods for the Baseline Model 162 5.3.3 *Arm-Based Meta-Analytic Models 162 5.3.4 Baseline Models with Covariates 164 5.3.4.1 Using Aggregate Data 164 5.3.4.2 Risk Equations for the Baseline Model Basedon Individual Patient Data 165 5.4 The Natural History Model 165 5.5 Model Validation and Calibration Through Multi-Parameter Synthesis 167 5.6 Generating the Outputs Required for Cost-Effectiveness Analysis 169 5.6.1 Generating a CEA 169 5.6.2 Heterogeneity in the Context of Decision-Making 170 5.7 Strategies to Implement Cost-Effectiveness Analyses 173 5.7.1 Bayesian Posterior Simulation: One-Stage Approach 174 5.7.2 Bayesian Posterior Simulation: Two-Stage Approach 174 5.7.3 Multiple Software Platforms and Automation of Network Meta-Analysis 175 5.8 Summary and Further Reading 177 5.9 Exercises 178 6 Adverse Events and Other Sparse Outcome Data 179 6.1 Introduction 179 6.2 Challenges Regarding the Analysis of Sparse Data in Pairwise and Network Meta-Analysis 180 6.2.1 Network Structure and Connectivity 182 6.2.2 Assessing Convergence and Model Fit 182 6.3 Strategies to Improve the Robustness of Estimation of Effects from Sparse Data in Network Meta-Analysis 183 6.3.1 Specifying Informative Prior Distributions for Response in Trial Reference Groups 183 6.3.2 Specifying an Informative Prior Distribution for the Between Study Variance Parameters 184 6.3.3 Specifying Reference Group Responses as Exchangeable with Random Effects 184 6.3.4 Situational Modelling Extensions 185 6.3.5 Specification of Informative Prior Distributions Versus Use of Continuity Corrections 186 6.4 Summary and Further Reading 186 6.5 Exercises 187 7 Checking for Inconsistency 189 7.1 Introduction 189 7.2 Network Structure 190 7.2.1 Inconsistency Degrees of Freedom 191 7.2.2 Defining Inconsistency in the Presence of Multi-Arm Trials 192 7.3 Loop Specific Tests for Inconsistency 195 7.3.1 Networks with Independent Tests for Inconsistency 195 7.3.1.1 Bucher Method for Single Loops of Evidence 195 7.3.1.2 Example: HIV 196 7.3.1.3 Extension of Bucher Method to Networks with Multiple Loops: Enuresis Example 197 7.3.1.4 Obtaining the ‘Direct’ Estimates of Inconsistency 199 7.3.2 Methods for General Networks 200 7.3.2.1 Repeat Application of the Bucher Method 201 7.3.2.2 A Back-Calculation Method 202 7.3.2.3 *Variance Measures of Inconsistency 202 7.3.2.4 *Node-Splitting 203 7.4 A Global Test for Loop Inconsistency 205 7.4.1 Inconsistency Model with Unrelated Mean Relative Effects 206 7.4.2 Example: Full Thrombolytic Treatments Network 210 7.4.2.1 Adjusted Standard Errors for Multi-Arm Trials 214 7.4.3 Example: Parkinson’s 215 7.4.4 Example: Diabetes 218 7.5 Response to Inconsistency 219 7.6 The Relationship between Heterogeneity and Inconsistency 221 7.7 Summary and Further Reading 223 7.8 Exercises 225 8 Meta-Regression for Relative Treatment Effects 227 8.1 Introduction 227 8.2 Basic Concepts 229 8.2.1 Types of Covariate 229 8.3 Heterogeneity, Meta-Regression and Predictive Distributions 232 8.3.1 Worked Example: BCG Vaccine 233 8.3.2 Implications of Heterogeneity in Decision Making 236 8.4 Meta-Regression Models for Network Meta-Analysis 238 8.4.1 Baseline Risk 241 8.4.2 WinBUGS Implementation 242 8.4.3 Meta-Regression with a Continuous Covariate 245 8.4.3.1 BCG Vaccine Example: Pairwise Meta-Regression with a Continuous Covariate 245 8.4.3.2 Certolizumab Example: Network Meta-Regression with Continuous Covariate 247 8.4.3.3 Certolizumab Example: Network Meta-Regression on Baseline Risk 252 8.4.4 Subgroup Effects 255 8.4.4.1 Statins Example: Pairwise Meta-Analysis with Subgroups 256 8.5 Individual Patient Data in Meta-Regression 257 8.6 Models with Treatment-Level Covariates 261 8.6.1 Accounting for Dose 261 8.6.2 Class Effects Models 263 8.6.3 Treatment Combination Models 264 8.7 Implications of Meta-Regression for Decision Making 266 8.8 Summary and Further Reading 268 8.9 Exercises 269 9 Bias Adjustment Methods 273 9.1 Introduction 273 9.2 Adjustment for Bias Based on Meta-Epidemiological Data 275 9.3 Estimation and Adjustment for Bias in Networks of Trials 278 9.3.1 Worked Example: Fluoride Therapies for the Prevention of Caries in Children 279 9.3.2 Extensions 285 9.3.3 Novel Agent Effects 286 9.3.4 Small-Study Effects 287 9.3.5 Industry Sponsor Effects 287 9.3.6 Accounting for Missing Data 288 9.4 Elicitation of Internal and External Bias Distributions from Experts 289 9.5 Summary and Further Reading 290 9.6 Exercises 291 10 *Network Meta-Analysis of Survival Outcomes 293 10.1 Introduction 293 10.2 Time-to-Event Data 294 10.2.1 Individual Patient Data 294 10.2.2 Reported Summary Data 295 10.2.3 Kaplan–Meier Estimate of the Survival Function 295 10.3 Parametric Survival Functions 296 10.4 The Relative Treatment Effect 298 10.5 Network Meta-Analysis of a Single Effect Measure per Study 300 10.5.1 Proportion Alive, Median Survival and Hazard Ratio as Reported Treatment Effects 300 10.5.2 Network Meta-Analysis of Parametric Survival Curves: Single Treatment Effect 300 10.5.3 Shared Parameter Models 301 10.5.4 Limitations 302 10.6 Network Meta-Analysis with Multivariate Treatment Effects 302 10.6.1 Multidimensional Network Meta-Analysis Model 302 10.6.1.1 Weibull 302 10.6.1.2 Gompertz 303 10.6.1.3 Log-Logistic and Log-Normal 303 10.6.1.4 Fractional Polynomial 304 10.6.1.5 Splines 304 10.6.2 Evaluation of Consistency 304 10.6.3 Meta-Regression 305 10.7 Data and Likelihood 305 10.7.1 Likelihood with Individual Patient Data 305 10.7.2 Discrete or Piecewise Constant Hazards as Approximate Likelihood 306 10.7.3 Conditional Survival Probabilities as Approximate Likelihood 307 10.7.4 Reconstructing Kaplan–Meier Data 307 10.7.5 Constructing Interval Data 308 10.8 Model Choice 308 10.9 Presentation of Results 309 10.10 Illustrative Example 310 10.11 Network Meta-Analysis of Survival Outcomes for Cost-Effectiveness Evaluations 319 10.12 Summary and Further Reading 320 10.13 Exercises 322 11 *Multiple Outcomes 323 11.1 Introduction 323 11.2 Multivariate Random Effects Meta-Analysis 324 11.3 Multinomial Likelihoods and Extensions of Univariate Methods 327 11.4 Chains of Evidence 328 11.4.1 A Decision Tree Structure: Coronary Patency 328 11.4.2 Chain of Evidence with Relative Risks: Neonatal Early Onset Group B Strep 330 11.5 Follow-Up to Multiple Time Points: Gastro-Esophageal Reflux Disease 332 11.6 Multiple Outcomes Reported in Different Ways: Influenza 335 11.7 Simultaneous Mapping and Synthesis 337 11.8 Related Outcomes Reported in Different Ways: Advanced Breast Cancer 342 11.9 Repeat Observations for Continuous Outcomes: Fractional Polynomials 344 11.10 Synthesis for Markov Models 345 11.11 Summary and Further Reading 347 11.12 Exercises 349 12 Validity of Network Meta-Analysis 351 12.1 Introduction 351 12.2 What Are the Assumptions of Network Meta-Analysis? 352 12.2.1 Exchangeability 352 12.2.2 Other Terminologies and Their Relation to Exchangeability 353 12.3 Direct and Indirect Comparisons: Some Thought Experiments 355 12.3.1 Direct Comparisons 356 12.3.2 Indirect Comparisons 359 12.3.3 Under What Conditions Is Evidence Synthesis Likely to Be Valid? 362 12.4 Empirical Studies of the Consistency Assumption 363 12.5 Quality of Evidence Versus Reliability of Recommendation 365 12.5.1 Theoretical Treatment of Validity of Network Meta-Analysis 365 12.5.2 GRADE Assessment of Quality of Evidence from a Network Meta-Analyses 366 12.5.3 Reliability of Recommendations Versus Quality of Evidence: The Role of Sensitivity Analysis 368 12.6 Summary and Further Reading 369 12.7 Exercises 373 Solutions to Exercises 375 Appendices 401 References 409 Index 447

Read more less

Book SynopsisTable of ContentsPreface to the 4th Edition xix Preface to the 3rd Edition xxi Preface to the 2nd Edition xxiii Preface to the 1st Edition xxv Introduction xxvii I Some Fundamental Stuff 1 1 First things first – the nature of data 3 Variables and data 3 Where are we going …? 5 The good, the bad, and the ugly – types of variables 5 Categorical data 6 Nominal categorical data 6 Ordinal categorical data 7 Metric data 8 Discrete metric data 8 Continuous metric data 9 How can I tell what type of variable I am dealing with? 10 The baseline table 11 II Descriptive Statistics 15 2 Describing data with tables 17 Descriptive statistics. What can we do with raw data? 18 Frequency tables – nominal data 18 The frequency distribution 19 Relative frequency 20 Frequency tables – ordinal data 20 Frequency tables – metric data 22 Frequency tables with discrete metric data 22 Cumulative frequency 24 Frequency tables with continuous metric data – grouping the raw data 25 Open‐ended groups 27 Cross‐tabulation – contingency tables 28 Ranking data 30 3 Every picture tells a story – describing data with charts 31 Picture it! 32 Charting nominal and ordinal data 32 The pie chart 32 The simple bar chart 34 The clustered bar chart 35 The stacked bar chart 37 Charting discrete metric data 39 Charting continuous metric data 39 The histogram 39 The box (and whisker) plot 42 Charting cumulative data 44 The cumulative frequency curve with discrete metric data 44 The cumulative frequency curve with continuous metric data 44 Charting time‐based data – the time series chart 47 The scatterplot 48 The bubbleplot 49 4 Describing data from its shape 51 The shape of things to come 51 Skewness and kurtosis as measures of shape 52 Kurtosis 55 Symmetric or mound‐shaped distributions 56 Normalness – the Normal distribution 56 Bimodal distributions 58 Determining skew from a box plot 59 5 Measures of location – Numbers R us 62 Numbers, percentages, and proportions 62 Preamble 63 N umbers, percentages, and proportions 64 Handling percentages – for those of us who might need a reminder 65 Summary measures of location 67 The mode 68 The median 69 The mean 70 Percentiles 71 Calculating a percentile value 72 What is the most appropriate measure of location? 73 6 Measures of spread – Numbers R us – (again) 75 Preamble 76 The range 76 The interquartile range (IQR) 76 Estimating the median and interquartile range from the cumulative frequency curve 77 The boxplot (also known as the box and whisker plot) 79 Standard deviation 82 Standard deviation and the Normal distribution 84 Testing for Normality 86 Using SPSS 86 Using Minitab 87 Transforming data 88 7 Incidence, prevalence, and standardisation 92 Preamble 93 The incidence rate and the incidence rate ratio (IRR) 93 The incidence rate ratio 94 Prevalence 94 A couple of difficulties with measuring incidence and prevalence 97 Some other useful rates 97 Crude mortality rate 97 Case fatality rate 98 Crude maternal mortality rate 99 Crude birth rate 99 Attack rate 99 Age‐specific mortality rate 99 Standardisation – the age‐standardised mortality rate 101 The direct method 102 The standard population and the comparative mortality ratio (CMR) 103 The indirect method 106 The standardised mortality rate 107 III The Confounding Problem 111 8 Confounding – like the poor, (nearly) always with us 113 Preamble 114 What is confounding? 114 Confounding by indication 117 Residual confounding 119 Detecting confounding 119 Dealing with confounding – if confounding is such a problem, what can we do about it? 120 Using restriction 120 Using matching 121 Frequency matching 121 One‐to‐one matching 121 Using stratification 122 Using adjustment 122 Using randomisation 122 IV Design and Data 125 9 Research design – Part I: Observational study designs 127 Preamble 128 Hey ho! Hey ho! it’s off to work we go 129 Types of study 129 Observational studies 130 Case reports 130 Case series studies 131 Cross‐sectional studies 131 Descriptive cross‐sectional studies 132 Confounding in descriptive cross‐sectional studies 132 Analytic cross‐sectional studies 133 Confounding in analytic cross‐sectional studies 134 From here to eternity – cohort studies 135 Confounding in the cohort study design 139 Back to the future – case–control studies 139 Confounding in the case–control study design 141 Another example of a case–control study 142 Comparing cohort and case–control designs 143 Ecological studies 144 The ecological fallacy 145 10 Research design – Part II: getting stuck in – experimental studies 146 Clinical trials 147 Randomisation and the randomised controlled trial (RCT) 148 Block randomisation 149 Stratification 149 Blinding 149 The crossover RCT 150 Selection of participants for an RCT 153 Intention to treat analysis (ITT) 154 11 Getting the participants for your study: ways of sampling 156 From populations to samples – statistical inference 157 Collecting the data – types of sample 158 The simple random sample and its offspring 159 The systematic random sample 159 The stratified random sample 160 The cluster sample 160 Consecutive and convenience samples 161 How many participants should we have? Sample size 162 Inclusion and exclusion criteria 162 Getting the data 163 V Chance Would Be a Fine Thing 165 12 The idea of probability 167 Preamble 167 Calculating probability – proportional frequency 168 Two useful rules for simple probability 169 Rule 1. The multiplication rule for independent events 169 Rule 2. The addition rule for mutually exclusive events 170 Conditional and Bayesian statistics 171 Probability distributions 171 Discrete versus continuous probability distributions 172 The binomial probability distribution 172 The Poisson probability distribution 173 The Normal probability distribution 174 13 Risk and odds 175 Absolute risk and the absolute risk reduction (ARR) 176 The risk ratio 178 The reduction in the risk ratio (or relative risk reduction (RRR)) 178 A general formula for the risk ratio 179 Reference value 179 N umber needed to treat (NNT) 180 What happens if the initial risk is small? 181 Confounding with the risk ratio 182 Odds 183 Why you can’t calculate risk in a case–control study 185 The link between probability and odds 186 The odds ratio 186 Confounding with the odds ratio 189 Approximating the risk ratio from the odds ratio 189 VI The Informed Guess – An Introduction to Confidence Intervals 191 14 Estimating the value of a single population parameter – the idea of confidence intervals 193 Confidence interval estimation for a population mean 194 The standard error of the mean 195 How we use the standard error of the mean to calculate a confidence interval for a population mean 197 Confidence interval for a population proportion 200 Estimating a confidence interval for the median of a single population 203 15 Using confidence intervals to compare two population parameters 206 What’s the difference? 207 Comparing two independent population means 207 An example using birthweights 208 Assessing the evidence using the confidence interval 211 Comparing two paired population means 215 Within‐subject and between‐subject variations 215 Comparing two independent population proportions 217 Comparing two independent population medians – the Mann–Whitney rank sums method 219 Comparing two matched population medians – the Wilcoxon signed‐ranks method 220 16 Confidence intervals for the ratio of two population parameters 224 Getting a confidence interval for the ratio of two independent population means 225 Confidence interval for a population risk ratio 226 Confidence intervals for a population odds ratio 229 Confidence intervals for hazard ratios 232 VII Putting it to the Test 235 17 Testing hypotheses about the difference between two population parameters 237 Answering the question 238 The hypothesis 238 The null hypothesis 239 The hypothesis testing process 240 The p‐value and the decision rule 241 A brief summary of a few of the commonest tests 242 Using the p‐value to compare the means of two independent populations 244 Interpreting computer hypothesis test results for the difference in two independent population means – the two‐sample t test 245 Output from Minitab – two‐sample t test of difference in mean birthweights of babies born to white mothers and to non‐white mothers 245 Output from SPSS_: two‐sample t test of difference in mean birthweights of babies born to white mothers and to non‐white mothers 246 Comparing the means of two paired populations – the matched‐pairs t test 248 Using p‐values to compare the medians of two independent populations: the Mann–Whitney rank‐sums test 248 How the Mann–Whitney test works 249 Correction for multiple comparisons 250 The Bonferroni correction for multiple testing 250 Interpreting computer output for the Mann–Whitney test 252 With Minitab 252 With SPSS 252 Two matched medians – the Wilcoxon signed‐ranks test 254 Confidence intervals versus hypothesis testing 254 What could possibly go wrong? 255 Types of error 256 The power of a test 257 Maximising power – calculating sample size 258 Rule of thumb 1. Comparing the means of two independent populations (metric data) 258 Rule of thumb 2. Comparing the proportions of two independent populations (binary data) 259 18 The Chi‐squared (χ2) test – what, why, and how? 261 Of all the tests in all the world – you had to walk into my hypothesis testing procedure 262 Using chi‐squared to test for related‐ness or for the equality of proportions 262 Calculating the chi‐squared statistic 265 Using the chi-squared statistic 267 Yate’s correction (continuity correction) 268 Fisher’s exact test 268 The chi‐squared test with Minitab 269 The chi‐squared test with SPSS 270 The chi‐squared test for trend 272 SPSS output for chi‐squared trend test 274 19 Testing hypotheses about the ratio of two population parameters 276 Preamble 276 The chi‐squared test with the risk ratio 277 The chi‐squared test with odds ratios 279 The chi‐squared test with hazard ratios 281 VIII Becoming Acquainted 283 20 Measuring the association between two variables 285 Preamble – plotting data 286 Association 287 The scatterplot 287 The correlation coefficient 290 Pearson’s correlation coefficient 290 Is the correlation coefficient statistically significant in the population? 292 Spearman’s rank correlation coefficient 294 21 Measuring agreement 298 To agree or not agree: that is the question 298 Cohen’s kappa (κ) 300 Some shortcomings of kappa 303 Weighted kappa 303 Measuring the agreement between two metric continuous variables, the Bland–Altmann plot 303 IX Getting into a Relationship 307 22 Straight line models: linear regression 309 Health warning! 310 Relationship and association 310 A causal relationship – explaining variation 312 Refresher – finding the equation of a straight line from a graph 313 The linear regression model 314 First, is the relationship linear? 315 Estimating the regression parameters – the method of ordinary least squares (OLS) 316 Basic assumptions of the ordinary least squares procedure 317 Back to the example – is the relationship statistically significant? 318 Using SPSS to regress birthweight on mother’s weight 318 Using Minitab 319 Interpreting the regression coefficients 320 Goodness‐of‐fit, R2 320 Multiple linear regression 322 Adjusted goodness‐of‐fit: R̄2 324 Including nominal covariates in the regression model: design variables and coding 326 Building your model. Which variables to include? 327 Automated variable selection methods 328 Manual variable selection methods 329 Adjustment and confounding 330 Diagnostics – checking the basic assumptions of the multiple linear regression model 332 Analysis of variance 333 23 Curvy models: logistic regression 334 A second health warning! 335 The binary outcome variable 335 Finding an appropriate model when the outcome variable is binary 335 The logistic regression model 337 Estimating the parameter values 338 Interpreting the regression coefficients 338 Have we got a significant result? statistical inference in the logistic regression model 340 The Odds Ratio 341 The multiple logistic regression model 343 Building the model 344 Goodness‐of‐fit 346 24 Counting models: Poisson regression 349 Preamble 350 Poisson regression 350 The Poisson regression equation 351 Estimating β1 and β2 with the estimators b0 and b1 352 Interpreting the estimated coefficients of a Poisson regression, b0 and b1 352 Model building – variable selection 355 Goodness‐of‐fit 357 Zero‐inflated Poisson regression 358 Negative binomial regression 359 Zero‐inflated negative binomial regression 361 X Four More Chapters 363 25 Measuring survival 365 Preamble 366 Censored data 366 A simple example of survival in a single group 366 Calculating survival probabilities and the proportion surviving: the Kaplan–Meier table 368 The Kaplan–Meier curve 369 Determining median survival time 369 Comparing survival with two groups 370 The log‐rank test 371 An example of the log‐rank test in practice 372 The hazard ratio 372 The proportional hazards (Cox’s) regression model – introduction 373 The proportional hazards (Cox’s) regression model – the detail 376 Checking the assumptions of the proportional hazards model 377 An example of proportional hazards regression 377 26 Systematic review and meta‐analysis 380 Introduction 381 Systematic review 381 The forest plot 383 Publication and other biases 384 The funnel plot 386 Significance tests for bias – Begg’s and Egger’s tests 387 Combining the studies: meta‐analysis 389 The problem of heterogeneity – the Q and I2 tests 389 27 Diagnostic testing 393 Preamble 393 The measures – sensitivity and specificity 394 The positive prediction and negative prediction values (PPV and NPV) 395 The sensitivity–specificity trade‐off 396 Using the ROC curve to find the optimal sensitivity versus specificity trade‐off 397 28 Missing data 400 The missing data problem 400 Types of missing data 403 Missing completely at random (MCAR) 403 Missing at Random (MAR) 403 Missing not at random (MNAR) 404 Consequences of missing data 405 Dealing with missing data 405 Do nothing – the wing and prayer approach 406 List‐wise deletion 406 Pair‐wise deletion 407 Imputation methods – simple imputation 408 Replacement by the Mean 408 Last observation carried forward 409 Regression‐based imputation 410 Multiple imputation 411 Full Information Maximum Likelihood (FIML) and other methods 412 Appendix: Table of random numbers 414 References 415 Solutions to Exercises 424 Index 457

Read more less

Book SynopsisThe concepts of cause and effect are critical to the field of program evaluation. Experimentally-designed evaluations—those that randomize to treatment and control groups—offer a convincing means for establishing a causal connection between a program and its effects. Experimental Evaluation Design for Program Improvement considers a range of impact evaluation questions, particularly those questions that focus on the impact of specific aspects of a program. Laura R. Peck shows how a variety of experimental evaluation design options can provide answers to these questions, and she suggests opportunities for experiments to be applied in more varied settings and focused on program improvement efforts.Trade ReviewPeck reminds us that the results from experiments only inform us about average effects, but more importantly provides us with the information necessary to look inside the "black box." -- Roger Boothroyd * Post-revision review *Experimental evaluations are feasible under the right conditions. This book is an excellent guide for evaluators that want to apply this underutilized design in their practice. -- Sebastian Galindo * Post-revision review * A sophisticated and well-written treatise of evaluation design to improve policies and programs. -- Katrin Anacker * pre-publication review *Table of ContentsList of Boxes, Figures, and Tables Volume Editors’ Introduction About the Author Acknowledgments Chapter 1 • Introduction The State of the Field The Ethics of Experimentation What This Book Covers Questions and Exercises Resources for Additional Learning Chapter 2 • Conceptual Framework: From Program Logic Model to Evaluation Logic Model Program Logic Model Evaluation Logic Model Conclusion Questions and Exercises Resources for Additional Learning Chapter 3 • The Basic Experimental Design Defined Random Assignment Explained The Basic (Two-Armed) Experimental Design To Have a Control Group or Not to Have A Control Group? Questions and Exercises Resources for Additional Learning Chapter 4 • Variants of the Experimental Design Multi-Armed Designs Factorial Designs Multistage Designs Staggered Introduction Designs Blended Designs Aligning Evaluation Design Options With Program Characteristics and Research Questions Conclusion Questions and Exercises Chapter 5 • Practical Considerations and Conclusion Some Practical Considerations Road Testing Principles for Conducting High-Quality Evaluation Questions and Exercises Resources for Additional Learning Appendix • Doing the Math and Other Technical Considerations Estimating Treatment Impacts How to Interpret Results Handling Treatment Group No-Shows and Control Group Crossovers Subgroup Analyses Conclusion Questions and Exercises Resources for Additional Learning References Glossary Index

Read more less

Book Synopsis"A rewarding read for anyone who wants to know the unvarnished truth about how science really gets done." - Financial TimesAmerican taxpayers spend $30 billion annually funding biomedical research, but over half of these studies can't be replicated due to poor experimental design, improper methods, and sloppy statistics. Bad science doesn't just hold back medical progress, it can sign the equivalent of a death sentence for terminal patients. In Rigor Mortis, Richard Harris explores these urgent issues with vivid anecdotes, personal stories, and interviews with the top biomedical researchers. We need to fix our dysfunctional biomedical system--before it's too late.

Read more less

Book SynopsisStanislav Grof’s first 17 years of research into nonordinary states of consciousness induced by LSD and other psychedelics led to a revolutionary understanding of the human psyche. His research was the impetus behind a vastly expanded cartography of the unconscious, including two new realms still unacknowledged by official academic circles--the perinatal domain, which holds memories of the various stages of birth, and the transpersonal domain, which mediates experiential identification with other species and mythic figures, visits to archetypal realms, access to past life memories, and union with the cosmic creative principle. The research presented in this book provides a map of the psyche that is essential for understanding such phenomena as shamanism and near death experiences as well as other nonordinary states of consciousness. This map has led to the development of important new therapies in psychiatry and psychology for treating mental conditions often seen as disease and therefore suppressed by medication. It also provides a new threshold to understanding and entering the numinous realm of spirit.Trade Review“The most significant development in the recent history of depth psychology, and the most important advance in the field since Freud and Jung themselves, has been the work of Stanislav Grof.” * Richard Tarnas, Ph.D., author of The Passion of the Western Mind *“A breakthrough work.” * Jean Houston, Ph.D., coauthor of The Varieties of Psychedelic Experience *“Stanislav Grof is the undisputed world authority on LSD and the human psyche, and this book provides the best cartography of consciousness for understanding the profound impact of entheogens on the mind.” * Alex Grey, artist and author of Sacred Mirrors and Transfigurations *“Dr. Stanislav Grof's LSD: Doorway to the Numinous is an extraordinary alchemical text that overturns many commonly held beliefs about the nature of individual identity and consciousness. Based on his 2,500 clinical sessions using LSD as a therapeutic tool before the substance was interdicted, Grof's book explores the vast dimensions of inner experience that have been ignored and marginalized by the mainstream. He also provides a theoretical framework for understanding these amazing experiences that synthesizes Freudian and Jungian insights into the dark matter of the unconscious and the primal drives that secretly impel us to act. A must-read for all serious students of consciousness.” * Daniel Pinchbeck, author of 2012: The Return of Quetzalcoatl and Breaking Open the Head *“I know of no work that so well incorporates the findings of Freud, Jung, and Rank, adding fresh insights that the methods of these psychotherapists could never have achieved. It certainly goes beyond Freud. It brings new clarification to Jung. It throws new light on the topic of death and resurrection symbolism, as well as on religious imagery. I do not doubt that others working in this field will find Dr. Grof's discoveries a basis for a whole new strategy of research.” * Joseph Campbell, author of The Hero with a Thousand Faces, The Masks of God, and Myths to Live By *“Stanislav Grof ’s research is the most important contribution to personality theory in several decades.” * Abraham Maslow, Ph.D., psychologist, cofounder of Humanistic and Transpersonal Psychology, and autho *“An exceptionally clear and readable introduction to the evolving psychology of the spirit--transpersonal psychology--that is one of the most exciting developments of our times. Grof is far and away one of the leading scientists exploring this field.” * Charles Tart, Ph.D., psychologist and author of States of Consciousness, PSI: Scientific Studies of *“Dr. Grof's studies of the mystical experience in LSD therapy represent an extremely valuable scientific approach to consciousness research from which many people can benefit.” * Chogyam Trungpa Rinpoche, Tibetan lama and author of Born in Tibet, Spiritual Materialism, and Medit *“Grof has had far and away more experience in psychedelic research than anyone else and has come up with the most comprehensive and helpful framework for interpreting the data in this bewildering area.” * Huston Smith, Ph.D., author of The World’s Religions and Beyond the Post-Modern Mind *“Grof marshals an impressive array of data and speculation in support of the timely demand that Western science acknowledge consciousness and its many nonordinary states.” * Richard Alpert (Ram Dass), Ph.D., psychologist, spiritual teacher, and author of Be Here Now, Grist *“A fascinating journey through previously uncharted realms of the psyche guided by one of the world’s foremost consciousness researchers. A remarkable account of the extraordinary depths of the human psyche.” * Frances Vaughan, Ph.D., psychologist and author of Awakening Intuition and The Inward Arc *" . . . Grof's engrossing state-of-the-science overview argues convincingly that continued LSD reserach will help patients, parents, policymakers, and even spiritual seekers." * Publishers Weekly, Feb 2009 *"Dr. Grof's efforts should be lauded and highly commended in the scientific and medical community. His clinical research is courageous and luminous to anyone who is conscious of the body's metaphysiology and higher energy dynamics. This field of research is as important to the human animal as molecular scientific inquiry into the etiology of neoplasias." * Dr. Ron Shane, reviewer, April 2009 *"Dr. Grof has helped to give us new ways of seeing the world . . . He has opened a link between the psyche and the spirit." * Nexus New Times Magazine, Sept/Oct 2009 *"For any serious student of psychedelics or psychology, this is an important read that should not be ignored. In terms of building a foundation for the future of the psychedelic movement and finding a place for psychedelics in society, LSD:Doorway to the Numinous is without question the text. Authoritative, insightful, and self-aware." * Psychedelic Press, UK, Feb 2010 *Table of Contents Acknowledgments Preface 1 General Introduction The LSD Controversy LSD and Its Effects in Human Beings Empirical Basis for a New Theoretical Framework Heuristic Value of LSD Research 2 Abstract and Aesthetic Experiences in LSD Sessions 3 Psychodynamic Experiences in LSD Sessions COEX Systems (Systems of Condensed Experience) Origin and Dynamics of COEX Systems Manifestation of COEX Systems in LSD Sessions Dynamic Interaction between the COEX Systems and Environmental Stimuli 4 Perinatal Experiences in LSD Sessions Perinatal Matrix I. Primal Union with the Mother (Intrauterine Experience before the Onset of Delivery) Perinatal Matrix II. Antagonism with the Mother (Contractions in a Closed Uterine System) Perinatal Matrix III. Synergism with the Mother (Propulsion through the Birth Canal) Perinatal Matrix IV. Separation from the Mother (Termination of the Symbiotic Union and Formation of a New Type of Relationship) Significance of Basic Perinatal Matrices in LSD Psychotherapy 5 Transpersonal Experiences in LSD Sessions Experiential Extension within the Framework of “Objective Reality” Temporal Expansion of Consciousness • Embryonal and Fetal Experiences • Ancestral Experiences • Collective and Racial Experiences • Phylogenetic (Evolutionary) Experiences • Past-Incarnation Experiences • Precognition, Clairvoyance, Clairaudience, and “Time Travels” Spatial Expansion of Consciousness • Ego Transcendence in Interpersonal Relationships and the Experience of Dual Unity • Identification with Other Persons • Group Identification and Group Consciousness • Animal Identification • Plant Identification • Oneness with Life and with All Creation • Consciousness of Inorganic Matter • Planetary Consciousness • Extraplanetary Consciousness • Out-of-Body Experiences, Traveling Clairvoyance and Clairaudience, “Space Travels,” and Telepathy Spatial Constriction of Consciousness • Organ, Tissue, and Cellular Consciousness Experiential Extension beyond the Framework of “Objective Reality” • Spiritistic and Mediumistic Experiences • Experiences of Encounters with Suprahuman Spiritual Entities • Experiences of Other Universes and Encounters with Their Inhabitants • Archetypal Experiences and Complex Mythological Sequences • Experiences of Encounters with Various Deities • Intuitive Understanding of Universal Symbols • Activation of the Chakras and Arousal of the Serpent Power (Kundalini) • Consciousness of the Universal Mind • The Supracosmic and Metacosmic Void Significance of Transpersonal Experiences in LSD Psychotherapy Transpersonal Experiences and Contemporary Psychiatry 6 Multidimensional and Multilevel Nature of the LSD Experience Environmental Stimuli and Elements of the Setting Personality of the Therapist and the Therapeutic Situation Present Life Situation Past Life History Early Childhood and Infancy Biological Birth and the Perinatal Period Embryonal and Fetal Existence Transindividual (Transpersonal and Transhuman) Sources Epilogue The Psychedelic Research Renaissance--A Review of Recent Psychedelic Psychotherapy Research by L. Jerome, Ph.D., Valerie Mojeiko, and Rick Doblin, Ph.D. Notes Index About the Author

Read more less

Book SynopsisBringing together a team of leading international experts in the field of research, this book provides an up-to-date and accessible overview of applied research methods in the prehospital environment. Written to support the needs of the paramedicine, emergency medicine and wider healthcare communities in this rapidly advancing research setting, the authors introduce the key areas of research design and methods, evidence-based practice, ethics and quality improvement for both the novice and the more advanced researcher. Relevant examples of prehospital research are also included to fully explain and illustrate the key approaches. High-quality, robust evidence is of the utmost importance to inform prehospital clinical practice and ensure better patient care. This book is essential reading for anyone interested in undertaking research within the prehospital or emergency care setting, including undergraduate and postgraduate students in paramedic science, medicine, nursing and allied health.Trade ReviewThis is an extremely useful text which maps and demystifies the research process for prospective students and practitioners interested in undertaking research in the pre-hospital and ambulance settings. The book covers key topics and offers guidance for dealing with the issues, in a language and style that is easy to follow. -- Professor Paresh Wankhade, Emergency Services Management Expert, Edge Hill University, UK.It’s all here in one book – what paramedics need to get them started on their journey into research. From basic principles to publication, the authors bring a unique prehospital care slant to explaining how research works, in a way which is clear and easy to grasp. -- Dr Alison Porter, Associate Professor in Health Services Research, Swansea University, UKAn easy to read and comprehensive resource for junior pre-hospital researchers. Very comprehensive and covered the nuances of the field well. I will absolutely be recommending this to my post-graduate students. -- Prof Karen Smith, Director Centre for Research and Evaluation, Ambulance Victoria

Read more less

Book SynopsisHow do we know whether a particular treatment really works? How reliable is the evidence? And how do we ensure that research into medical treatments best meets the needs of patients? These are just a few of the questions addressed in a lively and informative way in Testing Treatments. Brimming with vivid examples, Testing Treatments will inspire both patients and professionals. Building on the success of the first edition, Testing Treatments has now been extensively revised and updated. The Second Edition includes a thought-provoking chapter on screening, explaining why early diagnosis is not always better. Other new chapters explore how over-regulation of research can work against the best interests of patients, and how robust evidence from research can be drawn together to shape the practice of healthcare in ways that allow treatment decisions to be reached jointly by patients and clinicians. Testing Treatments urges everyone to get involved in improving current research and future treatment, and outlines practical steps that patients and doctors can take together.

Read more less

Book SynopsisWritten by dedicated and active professionals from different areas of the pharmaceutical, biomedical, and medtech sectors, this book provides information on job and career opportunities in various life sciences industries. It also contains useful tips to launch your own startup. The pharmaceutical, biomedical and medical technology sectors offer a wide range of employment opportunities to talented and motivated young graduates. However, many of these employment prospects are not well known to early career scientists, who concentrate primarily on the scientific and academic content of their fields of interest. The book is divided into five parts: Part 1 provides an academic perspective that focuses on the specific preparation required in the final years of study to embark on a successful career in the pharmaceutical and biomedical industries. In Part 2, industry experts discuss employment possibilities all along the drug or product life cycle, from discovery research and development to commercialisation. Part 3 follows, highlighting opportunities in support functions such as regulatory affairs or quality assurance. Part 4 focuses on additional opportunities in the wider biomedical sector, while Part 5 contains practical tips and training opportunities for entering the pharmaceutical and biomedical industries. In the epilogue, the authors reflect on this fascinating field and its career prospects. The book offers a multidisciplinary perspective on career opportunities in the pharmaceutical and biomedical industry to a wide range of students and young life scientists.Table of ContentsTitle: Career Options in the Pharmaceutical and Biomedical Industry: An Insider’s Guide Preface (Introduction) Part 1: Setting the scene Chapter 1:Life after Academia: Launching your Pharma/Biotech CareerChris van Schravendijk Chapter 2:Competences for PharmacistsJeffrey Atkinson & Chris van Schravendijk Chapter 3:Job and Career Opportunities in the Pharmaceutical Industry: An OverviewJosse R. Thomas Part 2: Opportunities along the drug/product life cycle Chapter 4:Career Opportunities in ToxicologyMark Martens & Miranda Cornet Chapter 5:Job Possibilities in Clinical ResearchBenedikt Van Nieuwenhove Chapter 6:How to Get and Develop a Career in a Market Access Role in the Medical Devices IndustryVito Palatino Chapter 7:Job Opportunities in Pharmaceutical MarketingVicky van den Nieuwenhuyzen Chapter 8:Working in Medical Affairs and Clinical Operations: Life-Changing CareersDrago Vuino et al. Chapter 9:The Role of Medical Science LiaisonRoberta Manfroni Chapter 10:Career Development for Physicians in the Biopharmaceutical IndustryAnke Van den Broeck & Ann Dhoore Part 3: Opportunities in Supportive Functions Chapter 11:Job and Career Opportunities in Regulatory Affairs/ScienceAnn Emmerechts and Josse R. Thomas Chapter 12:Job Opportunities in Clinical Research Quality AssuranceIris Gorter de Vries Chapter 13:Job Opportunities in Quality Assurance Related to Manufacturing of Medicinal ProductsMaaike Gons Part 4: Other Opportunities in the Pharmaceutical and Biomedical Sector Chapter 14:Careers Perspective in a Science and Technology ParkLaura Aldrovandi & Simona Sbardelatti Chapter 15:To be or not to be: Entrepreneurship and Enterprise Creation as a Way to Innovate in LifeSciencesBrian Cahill et al. Chapter 16:How to Become a Successful Hospital and Community PharmacistLilian M. Azzopardi Part 5: Practical tips and tricks Chapter 17:A Successful Career in the Life Sciences Industry: How to Write your Strongest Resumé andAce that InterviewSofie Paeps & Charlotte Peters Chapter 18:Skill Building for Career Advancement: Public Speaking and NetworkingHynda K. Kleinman Chapter 19:Training Opportunities for a Career in the Pharmaceutical and Biomedical Industry/SectorJosse R. Thomas Epilogue

Read more less

Book SynopsisThis book addresses current topics on pathogenic Vibrio spp. from a comprehensive and holistic perspective. Here, experts in the field provide timely chapters, ranging from genomics, pathogen emergence, and epidemiology to pathogenesis, virulence regulation and host colonization. Questions addressed include: How does climate change affect the spread of these bacteria? What is the status of current vaccines? Are there novel therapeutic options to treat Vibrio infections? Is there likelihood of emergence of new pathogenic strains or species? Can insights from mathematical models and epidemiology lead to prediction of pathogen outbreaks?Recent decades have seen a steady increase in Vibrio spp. infections originating in aquatic and marine habitats, driven by higher human population densities, warming of polluted oceans, natural and human-made disasters, and mass seafood production. These conditions increase the likelihood of pathogenic Vibrio spp. coming into contact with humans, making their study even more timely and relevant as these problems escalate over time. This book is a valuable resource for health management professionals, experienced microbiologists/ microbial ecologists, and early career scientists alike who want to learn more about these important environmental human pathogens. The ideas and technologies presented in this book for preventing, controlling, and monitoring Vibrio spp. infections contribute to the UN Sustainable Development Goal 3: Good Health and Well-Being. Table of ContentsChapter 1. Vibrio Infections and the Twenty-First Century.- Chapter 2. New Insights into Vibrio Cholerae Biofilms from Molecular Biophysics to Microbial Ecology.- Chapter 3. Type VI Secretion Systems: Environmental and Intra-Host Competition of Vibrio cholerae.- Chapter 4. Motility Control as a Possible Link Between Quorum Sensing to Surface Attachment in Vibrio Species.- Chapter 5. The Vibrio Polar Flagellum: Structure and Regulation.- Chapter 6. Environmental Reservoirs of Pathogenic Vibrio Spp. and Their Role in Disease: The List Keeps Expanding.- Chapter 7. Cholera Dynamics and the Emergence of Pandemic Vibrio cholerae.- Chapter 8. Role of Bacteriophages in the Evolution of Pathogenic Vibrios and Lessons for Phage Therapy.- Chapter 9. Vibrio vulnificus, an Underestimated Zoonotic Pathogen.- Chapter 10. The Role of Nutrients and Nutritional Signals in the Pathogenesis of Vibrio cholerae.- Chapter 11. Stress Responses in Pathogenic Vibrios and Their Role in Host and Environmental Survival.- Chapter 12. Vibrio parahaemolyticus Epidemiology and Pathogenesis: Novel Insights on an Emerging Foodborne Pathogen.- Chapter 13. The Viable but Non-Culturable (VBNC) State in Vibrio Species: Why Studying the VBNC State Now, Is More Exciting than Ever.- Chapter 14. Structural Insights into Regulation of Vibrio Virulence Gene Networks.- Chapter 15. When Vibrios Take Flight: A Meta-Analysis of Pathogenic Vibrio Species in Wild and Domestic Birds.- Chapter 16. What Whole Genome Sequencing Has Told Us About Pathogenic Vibrios.

Read more less

Book SynopsisThis book provides a comprehensive account of the current status of molecular hydrogen medicine, a young field that emerged with the discovery that inhalation of hydrogen gas leads to the elimination of harmful reactive oxygen species in rats. Various physiologic effects have since been demonstrated, and possible medical applications identified. Numerous clinical projects have now been undertaken, yielding startling results. Despite this, molecular hydrogen medicine remains underappreciated among the medical community at large. The author aims to rectify this situation by fairly but critically evaluating the potential clinical benefits based on the latest scientific research. In addition, the observed physiological effects of hydrogen gas are considered within the broad context of the evolution of life on earth, offering new perspectives and helping to place molecular hydrogen medicine legitimately within the framework of life sciences. Written in an accessible manner, the book will be of value to students, researchers, clinicians, and the general public. Table of ContentsPart I What is Molecular Hydrogen Medicine?.- Chapter 1 The power of hydrogen molecules uncovered.- Chapter 2 Development of Molecular Hydrogen Medicine.- Chapter 3 From the front-line of research – Interviews.- Chapter 4 Physiological effects of the hydrogen molecule.- Chapter 5 Some fundamental properties of hydrogen and water.- Chapter 6 Functions of heavy water in living organisms.- Chapter 7 The future of Molecular Hydrogen Medicine.- Part II Tracing the History of Life and Hydrogen.- Chapter 8 The genesis of life in the world of hydrogen, Eons ago- Chapter 9 Drastic changes of living organisms in the oxygen age.- Chapter 10 Since the appearance of humans.

Read more less

Book Synopsis''Her stories have the power to transform your life'' Lori Gottlieb, bestselling author of Maybe You Should Talk to Someone ''Radically changes the way we think about mental illness, pleasure, pain, reward and stress'' Daniel Levitin, bestselling author of The Organized MindTHE NEW YORK TIMES AND SUNDAY TIMES BESTSELLER We are a wired generation. In these fast-paced times we are constantly bombarded by high-reward, high-dopamine stimuli. From texting to social media, food to drugs, gambling to shopping, we have become addicted to fleeting and distracting pleasures that are making us sick.In Dopamine Nation, psychiatrist and bestselling author Dr Anna Lembke reveals why our relentless pursuit of pleasure leads to pain and what we can do about it. Bringing together cutting-edge neuroscience with the gripping real life experiences from her clinical practice, Lembke explores how contentment and connTrade ReviewAnna Lembke's stories of guiding people to find a healthy balance between pleasure and pain have the power to transform your life -- Lori Gottlieb, bestselling author of Maybe You Should Talk to SomeoneBrilliant . . . No matter what you might find yourself over-indulging in-from the internet to food to work to sex-you'll find this book riveting, scary, cogent, and cleverly argued. Lembke weaves patient stories with research, in a voice that's as empathetic as it is clear-eyed -- Beth Macy, bestselling author of DopesickRadically changes the way we think about mental illness, pleasure, pain, reward, and stress. Turn toward it. You'll be happy you did -- Daniel Levitin, bestselling author of The Organized Mind and Successful Aging[An] eye-opening survey on pleasure-seeking and addiction . . . Readers looking for balance will return to Lembke's informative and fascinating guidance. * Publishers Weekly, starred review *fascinating case histories, and a sensible formula for treatment. * Kirkus Reviews *Dr Anna Lembke is a whiz on why we get hooked on things - and how we can enjoy pleasurable things in healthier doses * Guardian *

Read more less

Book SynopsisA good understanding of medical statistics is essential to evaluate medical research and to choose appropriate ways of implementing findings in clinical practice. The Oxford Handbook of Medical Statistics has been written to provide doctors and medical students with a comprehensive yet concise account of this often difficult subject. Described by readers as a ''statistical Bible'', this new edition maintains the accessibility and thoroughness of the original, and includes comprehensive updates including new sections on transitional medicine, cluster designs, and modern statistical packages. The Handbook promotes understanding and interpretation of statistical methods across a wide range of topics, from study design and sample size considerations, through t- and chi-squared tests, to complex multifactorial analyses, all using examples from published research. References and further reading are included, to allow deeper understanding on specific topics. Featuring a new chapter on how to use this book in different medical contexts, the Oxford Handbook of Medical Statistics helps readers to conduct their own research and critically appraise others'' work.Trade ReviewReview from previous edition 'I am a student of the Masters in Public Health. I just wanted to let you know that I have really enjoyed the classes you taught as well as the book that you've written (the oxford handbook of medical statistics). I found the book a breath of fresh air when revising for my exams- the explanations so clear and concise, straight to the point. Statistics really do make sense when explained like this. Thank you for providing such a useful tool.' * Alicia Rosello, King's College London *Table of Contents1: How to use the Oxford Handbook of Medical Statistics 2: Research design 3: Collecting data 4: Handling data: what steps are important 5: Presenting research findings 6: Choosing and using statistical software 7: Summarising data 8: Probability and distributions 9: Statistical tests 10: Diagnostic studies 11: Other statistical methods/topics 12: Analysing multiple observations per subject 13: Analysing multiple variables per subject 14: Meta analysis 15: Bayesian statistics 16: Glossary

Read more less

Book Synopsis'Louise is a voice you can really trust. I've learnt so much from her and now you can too.' - Holly Willoughby 'Dr Louise is a miracle worker' - Lorraine Kelly 'Louise is my No. 1 go-to when it comes to anything menopause and this book is perfect for when I'm worried about anything.'- Alison Hammond 'Louise Newson is wonderful... a real expert in her field.' - Joe WicksYour complete, expert, evidence-based guide to the perimenopause and menopause. Dr Louise Newson is fast becoming the leading medical expert on hormone health. This revised and expanded edition of her bestselling book has all the information and advice you need to understand the impact of low hormone levels on your perimenopause symptoms as well as on your future health post-menopause. There's an up-to-date guide to HRT doses, how to deal with HRT availability fluctuations, new research on testosterone and its benefits bey

Read more less

Book SynopsisPursuing a career in biomedical research can be daunting, considering the stiffer competition and uncertain career prospects in academia. This book summarizes career advice gathered during in-depth interviews with 106 biomedical scientists who lead their own laboratories. The participating principal investigators are from 44 research institutions in 11 countries. This book is unique in that it provides a glimpse into the mindset of principal investigators. Here, the reader will learn about common thought patterns and values, as well as the range of opinions and ways of thinking to be found among a large group of active principal investigators – without having to read more than a hundred individual autobiographies.The book will benefit all PhD students who want to learn more about their supervisor’s mindset in order to successfully complete their projects. It can help freshly graduated PhDs planning to pursue an academic career, and MDs contemplating a career in research, to decide whether they truly want to embark on this path. Lastly, it can offer young principal investigators a source of inspiration on how to succeed and achieve their goals.Table of ContentsTable of Contents Chapter 1. “Carving Your Own Path” – shaping your scientific identity Chapter 2. The Two Cornerstones of Academic Research: Writing Grant Applications and Publications Chapter 3. Setting up a Successful Research Group Chapter 4. Leading Your Research Group as a Principal Investigator Chapter 5. The Daily Work of Principal Investigators Chapter 6. Dealing with Failure and Stress in Academic Research Chapter 7. Thoughts of Principal Investigators about Work, Science, and Themselves Chapter 8. Under the Hood – Common Thinking Patterns of Principal Investigators Chapter 9. Epilogue Chapter 10. Methods References Recommended reading

Read more less

Book Synopsis

Read more less

Book SynopsisPublisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.Provides immediate help for anyone preparing a biomedical paper by givin specific advice on organizing the components of the paper, effective writing techniques, writing an effective results sections, documentation issues, sentence structure and much more. The new edition includes new examples from the current literature including many involving molecular biology, expanded exercises at the end of the book, revised explanations on linking key terms, transition clauses, uses of subheads, and emphases. If you plan to do any medical writing, read this book first and get an immediate advantage.Trade Review"In summary, Zeiger's thoroughness, combined with the clarity of the examples used to illustrate each principle of clear writing, are the book's strengths. We recommend Essentials of Writing Biomedical Research Papers to students, editors, and writers at all levels who want to master IMRAD format or learn techniques that will improve their writing."--American Medical Writers Association American Medical Writers Association 20010101Table of ContentsPreface. Credits. The Goal: Clear Writing. Section I: The Building Blocks of Writing. Chapter 1: Word Choice. Chapter 2: Sentence Structure. Chapter 3: Paragraph Structure. Section II: The Text of the Biomedical Research Paper. Chapter 4: The Introduction. Chapter 5: Materials and Methods. Chapter 6: Results. Chapter 7: Discussion. Section III: Supporting Information. Chapter 8: Figures and Tables. Chapter 9: References. Section IV: The Overview. Chapter 10: The Abstract. Chapter 11: The Title. Chapter 12: The Big Picture. Reaching the Goal: Suggestions for Writing. Revisions of Exercises. Literature Cited. Index.

Read more less

Book SynopsisThis handbook digests and presents the key trials influencing current clinical practice, selected and summarised by figureheads in the medical and surgical specialties. The handbook format allows readers to quickly access and assimilate the evidence behind the practices and interventions experienced every day.Trade ReviewReview from previous edition Each chapter is well laid-out, the summaries are easy to read and the take-home message and statistics are highlighted...This book should become a valuable tool for medical students and junior doctors alike. * Oxford Medical School Gazette *Table of ContentsINTRODUCTION; MEDICAL SPECIALTIES; SURGICAL SPECIALTIES

Read more less

Book SynopsisAssesses the nation's future needs for biomedical and behavioral scientists and the role the National Research Service Awards (NRSA) program can play in meeting those needs. The NRSA program has made it possible for thousands of individuals in the basic biomedical, behavioral, and clinical sciences to sharpen their research skills.Table of Contents1 FRONT MATTER; 2 EXECUTIVE SUMMARY; 3 1 INTRODUCTION; 4 2 APPROACHES TO THE ESTIMATION OF NATIONAL NEED; 5 3 BASIC BIOMEDICAL SCIENCES PERSONNEL; 6 4 BEHAVIORAL SCIENCES PERSONNEL; 7 5 PHYSICIAN-SCIENTISTS; 8 6 ORAL HEALTH RESEARCH PERSONNEL; 9 7 NURSING RESEARCH PERSONNEL; 10 8 HEALTH SERVICES RESEARCH PERSONNEL; 11 9 RECOMMENDATIONS AND REMAINING CONSIDERATIONS; 12 APPENDIX A: HISTORICAL OVERVIEW; 13 APPENDIX B: CLASSIFICATION OF FIELDS; 14 APPENDIX C: PUBLIC HEARING ON NATIONAL NEEDS FOR BIOMEDICAL AND BEHAVIORAL RESEARCH PERSONNEL; 15 APPENDIX D: REPORT CONTRIBUTORS; 16 APPENDIX E: SOURCES OF INFORMATION FOR THE NATIONAL RESEARCH SERVICE AWARD; 17 APPENDIX F: DATA TABLES; 18 APPENDIX G: MULTISTATE LIFE TABLE METHODOLOGY AND PROJECTIONS; 19 APPENDIX H: PROCEDURES USED TO ESTIMATE AWARDS, STIPENDS, AND COSTS; 20 APPENDIX I: BIOGRAPHICAL SKETCHES

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Table of Contents1 Front Matter; 2 Summary; 3 1 Introduction and Context; 4 2 CIRM's Initial Processes and Funding Model; 5 3 CIRM's Governance Structure; 6 4 Nature, Scope, and Accomplishments of the CIRM Scientific Program; 7 5 CIRM's Intellectual Property Policies; 8 Glossary; 9 Appendix A: Data Sources and Methods; 10 Appendix B: Summary of Questionnaires; 11 Appendix C: Proposition 71; 12 Appendix D: Senate Bill 1064; 13 Appendix E: Committee Biographies

Read more less

Book Synopsis

Read more less

Book Synopsis'The author gives an excellent overview and explores how children have been seen as objects and subjects in research as well as increasingly as participants and more recently still as researchers.'- International Journal of Research and Method in Education'This book is especially beneficial in terms of its breadth of discussion on the legal, ethical and moral issues of conducting research with children and young people alongside the key methodological challenges that students and practitioners are faced when conducting this type of research' - Research Policy and PlanningDoing Research with Children and Young People introduces researchers to the key considerations involved in working with children and young people. The book highlights issues which arise at different stages in the process and which all researchers need to take account of as they plan and carry out a study. These include: ethicalTable of ContentsDoing Research with Children and Young People - Vicky Lewis An Introduction PART ONE: SETTING THE CONTEXT Situating Empirical Research - Sandy Fraser Images of Childhood - Mary Kellett, Chris Robinson and Rachel Burr The Legal Context - Judith Masson Paradigms and Philosophy - Sandy Fraser and Chris Robinson PART TWO: RESEARCH RELATIONS Power - Chris Robinson and Mary Kellett Ethics - Priscilla Alderson Involving Children and Young People as Researchers - Adele Jones Gender - Rob Pattman and Mary Jane Kehily PART THREE: DIVERSITY Early Childhood - Ann Langston et al Middle Childhood - Mary Kellett and Sharon Ding Young People - Alan France Disability - Vicky Lewis and Mary Kellett Participatory Action Research in the Majority World - Olga Nieuwenhuys Race and Ethnicity - Mani Maniam et al PART FOUR: RELEVANCE, EVALUATION AND DISSEMINATION Health and Social Care - Helen Roberts Education - Ann Edwards Childhood Studies - Jim McKechnie and Sandy Hobbs

Read more less

Book SynopsisContaining helpful summaries and checklists throughout and based on Mazur's thirty years of research experience, this accessible and informative guide will give all IRB members the tools they need to protect human lives and facilitate the research process.Trade ReviewA well-written and informative narrative of the inner workings of IRBs. It is a must-read for those who are (or will be) members of an IRB and for those who need to submit a proposal. -- Maura Pilotti, Ph.D. Metapsychology 2007 An indispensable guide for both experienced and inexperienced IRB members... I would recommend it to any IRB member. Doody's Review Service 2007 Mazur's book provides IRB members with essential questions they should ask when reviewing proposed and ongoing studies. -- Karen J. Maschke New England Journal of Medicine 2007 The book contains an interesting perspective and a wealth of knowledge. It contains quite a lot of information for any single audience, but those who serve on IRBs can benefit greatly from reading and referring to Mazur's work. -- Alice Z. Frohna JAMA 2007 College-level holdings strong in medical and research issues or medical ethics will want this review. Midwest Book Review 2007 There is much to like about Evaluating the Science and Ethics of Research on Humans; its depth and sophistication... Not just Mazur's experience but the overall evolution of research administration is reflected in this volume. -- Kenneth A. DeVille Journal of Legal Medicine 2007 Every IRB member must read this book so that the participants of clinical trials benefit from it. -- Sanjay A. Pai Indian Journal of Medical Ethics 2008 The author applies extensive experience to illustrate the depth of ethical reflection that research proposals can generate and provides guidance on how reflection can be directed to decision making... Checklists in the text and appendices afford IRB members and officers the comfort of knowing that little, if anything, has been overlooked in discharging ethics review. -- Bernard M. Dickens, PhD Annals of Internal Medicine 2008 The analysis of a study's risk-benefit ratio is especially good. U.S. Dept. of Energy, Office of Biological and Environmental Research 2007 Contains helpful summaries and checklists throughout based on the author's thirty years of research experience. Issues in Law and Medicine 2008Table of ContentsPrefaceIntroduction: What Can the New IRB Member Expect?Part I: The IRB, Its Work, and Its Challenges1. What Is an IRB, and What Does It Do?2. Basic Terms and Concepts Used in IRB Work3. What Is Risk?Part II: The Scientific Protocol and the Informed Consent Form4. Prescreening of Proposals5. The Scientific Protocol6. The Informed Consent Form7. Recruitment, Selection, and Compensation of Study Participants8. Research involving Questionnaires and Surveys9. Protection of Participants' Privacy in Research Dataand SpecimensPart III: The Continuing Work of the IRB10. The Ethical Issues of Informed Consent11. Continuing Review, Communication, and Feedback12. Where Are IRBs Making Mistakes, and How Can We Minimize Mistakes?13. Strategies for Managing the IRB Workload and Supporting IRB Decision Making14. Decision-Making Capacity and Accountability in ResearchSummary: The IRB's Key RoleAppendix 1: A Check List for Reviewing a Scientific ProtocolAppendix 2: A Check List for Reviewing an Informed Consent FormNotesWebsite References for Cited DocumentsIndex

Read more less

Book SynopsisIntegrated Drug Discovery Technologies provides a global overview of emerging drug development technologies by presenting and integrating new techniques from the disciplines of chemistry, biology, and computational sciences. It combines integration of contemporary mechanization with strategies in drug delivery. Topics include: functional genomics, microfabrication techniqes, integrated proteomics technologies, high throughput screening, and fluorescence correlation spectroscopy methods.Table of ContentsFrom gene to screen: target identification and validation Coupling Genotype to Phenotype; functional genomics; integrated proteomics technologies; where science meets silicone - microfabrication techniques and their scientific applications; SNP scoring for drug discovery applications; protein display chips; integrated proteomics technologies and in vitro validation of molecular tests. High throughput screening: high throughput screening as a discovery resource; fluorescence correlation spectroscopy (FCS) and FCS-related confocal fluorimetric methods (FCS + plus) multiple read-out options or miniaturized screening; homogeneous time-resolved fluorescence (HTRF); ADME-tox screening in drug discovery; screening lead compounds in the post-genomic era - an integrated approach to knowledge building from living cells.

Read more less

Book SynopsisEconomists advocate regulation and tailored incentives to stimulate improvement activities. Such activities should be adopted if their benefits outweigh their costs. This title is also available as Open Access on Cambridge Core.Table of Contents1. Introduction; 2. The Economic Approach to Healthcare Improvement; 3. Stimulating Healthcare Improvement; 4. Evaluating Healthcare Improvement Activities; 5. Critiques of the Approach; 6. Further Research; 7. Conclusions; 8. Further Reading; Contributors; References.

Read more less

Book SynopsisMicrosystems are the building blocks of the healthcare system. They are the small functional frontline units that provide most healthcare to most people, be it a clinic or a ward. The microsystem improvement approach engages teams at the frontline of care with patients and families in a structured process to improve the quality of care and outcomes. This Element offers an overview of the theory of the microsystems, mesosystems, and team coaching improvement approaches, using case studies to demonstrate how the approaches have been used in practice. A critique of the emerging evidence base and the strengths and limitations of the approach is given. This title is also available as open access on Cambridge Core.

Read more less

Book Synopsis

Read more less